NOMD vs. BMY
NOMD (Nomad Foods Limited) and BMY (Bristol-Myers Squibb Company) are both stocks. NOMD operates in Packaged Foods (Consumer Defensive), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, NOMD returned 4.24%/yr vs 2.16%/yr for BMY. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
NOMD vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NOMD achieves a -1.85% return, which is significantly lower than BMY's 25.17% return. Over the past 10 years, NOMD has outperformed BMY with an annualized return of 4.24%, while BMY has yielded a comparatively lower 2.16% annualized return.
NOMD
- 1D
- -4.11%
- 1M
- 4.20%
- 6M
- -3.32%
- YTD
- -1.85%
- 1Y
- -25.84%
- 3Y*
- -9.31%
- 5Y*
- -12.68%
- 10Y*
- 4.24%
- ALL TIME*
- 0.83%
BMY
- 1D
- 0.69%
- 1M
- 12.35%
- 6M
- 21.21%
- YTD
- 25.17%
- 1Y
- 54.75%
- 3Y*
- 6.92%
- 5Y*
- 3.38%
- 10Y*
- 2.16%
- ALL TIME*
- 9.43%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $711.50M | $665.03M | $681.59M | |
| $19.32M | $16.84M | $16.30M |
NOMD vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOMD Nomad Foods Limited | -1.85% | -22.15% | 2.39% | -1.68% | -32.10% | -0.12% | 13.63% | 33.79% | -1.12% | 76.70% |
BMY Bristol-Myers Squibb Company | 25.17% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between NOMD and BMY is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016 | 0.19 |
Fundamentals
NOMD:
$1.66B
BMY:
$133.37B
NOMD:
€0.92
BMY:
$4.54
NOMD:
11.21
BMY:
14.37
NOMD:
18.10
BMY:
0.82
NOMD:
0.50
BMY:
2.71
NOMD:
0.59
BMY:
5.99
NOMD:
€3.00B
BMY:
$49.19B
NOMD:
€798.02M
BMY:
$34.51B
NOMD:
€343.69M
BMY:
$16.67B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOMD vs. BMY — Risk / Return Rank
NOMD
BMY
NOMD vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nomad Foods Limited (NOMD) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOMD | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.92 | ||
| Sortino ratioReturn per unit of downside risk | -4.07 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.36 | -0.48 |
| Calmar ratioReturn relative to maximum drawdown | -0.58 | 4.66 | -5.23 |
| Martin ratioReturn relative to average drawdown | -0.84 | 11.09 | -11.93 |
Loading charts...
Drawdowns
NOMD vs. BMY - Drawdown Comparison
The maximum NOMD drawdown since its inception was -67.99%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for NOMD and BMY.
Loading charts...
Drawdown Indicators
| NOMD | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.99% | -72.03% | +4.04% |
Max Drawdown (1Y)Largest decline over 1 year | -43.85% | -12.53% | -31.32% |
Max Drawdown (3Y)Largest decline over 3 years | -52.77% | -34.11% | -18.66% |
Max Drawdown (5Y)Largest decline over 5 years | -64.82% | -47.67% | -17.15% |
Max Drawdown (10Y)Largest decline over 10 years | -67.99% | -47.67% | -20.32% |
Current DrawdownCurrent decline from peak | -58.09% | -4.95% | -53.14% |
Average DrawdownAverage peak-to-trough decline | -25.76% | -22.36% | -3.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.24% | 5.25% | +24.99% |
Volatility
NOMD vs. BMY - Volatility Comparison
The current volatility for Nomad Foods Limited (NOMD) is 8.61%, while Bristol-Myers Squibb Company (BMY) has a volatility of 9.10%. This indicates that NOMD experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOMD | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.61% | 9.10% | -0.49% |
Volatility (6M)Calculated over the trailing 6-month period | 26.11% | 19.64% | +6.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.67% | 27.86% | +4.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.65% | 24.49% | +5.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.36% | 25.46% | +2.90% |
Dividends
NOMD vs. BMY - Dividend Comparison
NOMD's dividend yield for the trailing twelve months is around 5.71%, more than BMY's 3.84% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 3.84% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
NOMD Nomad Foods Limited | 5.71% | 5.44% | 3.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NOMD vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nomad Foods Limited and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NOMD vs. BMY - Profitability Comparison
NOMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nomad Foods Limited reported a gross profit of 186.62M and revenue of 726.96M. Therefore, the gross margin over that period was 25.7%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a gross profit of 9.25B and revenue of 12.97B. Therefore, the gross margin over that period was 71.3%.
NOMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nomad Foods Limited reported an operating income of 67.70M and revenue of 726.96M, resulting in an operating margin of 9.3%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported an operating income of 4.09B and revenue of 12.97B, resulting in an operating margin of 31.5%.
NOMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nomad Foods Limited reported a net income of 29.38M and revenue of 726.96M, resulting in a net margin of 4.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a net income of 3.32B and revenue of 12.97B, resulting in a net margin of 25.6%.
Frequently Asked Questions
NOMD and BMY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (9.10%) compared to NOMD (8.61%). In terms of maximum drawdown, NOMD dropped -67.99% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (2.14 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NOMD and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer